Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor

Molecular Pharmaceutics

Volumn 8, Issue 4, 2011, Pages 1322-1331

  Dubey, S ^a   Perozzo, R ^a   Scapozza, L ^a   Kalia, Y N ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

formulation; human basic fibroblast growth factor (hbFGF); noninvasive; peripheral arterial disease; protein delivery; transdermal iontophoresis; wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PARACETAMOL;

ANIMAL TISSUE; ARTICLE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG STABILITY; DRUG TRANSPORT; ELECTROOSMOSIS; FEASIBILITY STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IONTOPHORESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SWINE;

ACETAMINOPHEN; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROOSMOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; FORESKIN; HUMANS; IONTOPHORESIS; MALE; MICE; MICROSCOPY, CONFOCAL; NIH 3T3 CELLS; RHODAMINES; SKIN; SWINE;

EID: 79961082135     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp200125j     Document Type: Article

References (51)

1. Kalia, Y. N.; Naik, A.; Garrison, J.; Guy, R. H. Iontophoretic drug delivery Adv. Drug Delivery Rev. 2004, 56, 619-658 (Pubitemid 38326937)
2. Green, P. G. Iontophoretic delivery of peptide drugs J. Controlled Release 1996, 41, 33-48 (Pubitemid 26246361)
3. Cazares-Delgadillo, J.; Naik, A.; Ganem-Rondero., A.; Quintanar-Guerrero., D.; Kalia, Y. N. Transdermal delivery of cytochrome C-a 12.4 kDa protein-across Intact skin by constant-current iontophoresis Pharm. Res. 2007, 24, 1360-1368 (Pubitemid 46870601)
4. Dubey, S.; Kalia, Y. N. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins J. Controlled Release 2010, 145, 203-209
5. Zhang, J.; Cousenst, L. S.; Barrt, P. J.; Sprang, S. R. Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1β Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 3446-3450 (Pubitemid 21916638)
6. Kurokawa, I.; Hayami, J.; Kita, Y. A therapy-resistant chronic leg ulcer treated successfully with topical basic fibroblast growth factor J. Int. Med. Res. 2003, 31, 149-151 (Pubitemid 36553314)
7. Yamanaka, K.; Inaba, T.; Nomura, E.; Hurwitz, D.; Jones, D. A.; Hakamada, A.; Isoda, K.; Kupper, T. S.; Mizutani, H. Basic fibroblast growth factor treatment for skin ulcerations in scleroderma Cutis 2005, 76, 373-376 (Pubitemid 43104480)
8. O'Goshi, K.; Tagami, H. Basic fibroblast growth factor treatment for various types of recalcitrant skin ulcers: Reports of nine cases J. Dermatol. Treat. 2007, 18, 375-381 (Pubitemid 350223203)
9. Uchi, H.; Igarashi, A.; Urabe, K.; Koga, T.; Nakayama, J.; Kawamori, R.; Tamaki, K.; Hirakata, H.; Ohura, T.; Furue, M. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer Eur. J. Dermatol. 2009, 19, 461-468
10. Akita, S.; Akino, K.; Imaizumi, T.; Hirano, A. A fibroblast growth factor improved the quality of skin grafting in burn patients Burns 2005, 31, 855-858 (Pubitemid 41394142)
11. Akita, S.; Akino, K.; Imaizumi, T.; Tanaka, K.; Anraku, K.; Yano, H.; Hirano, A. The quality of pediatric burn scars is improved by early administration of basic fibroblast growth factor J. Burn Care Res. 2006, 27, 333-338 (Pubitemid 43970300)
12. Akita, S.; Akino, K.; Imaizumi, T.; Hirano, A. Basic fibroblast growth factor accelerates and improves second-degree burn wound healing Wound Repair Regen. 2008, 16, 635-641
13. Akasaka, Y; Ono, I.; Yamashita, T; Jimbow, K; Ishii, T. Basic fibroblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds J. Pathol. 2004, 203, 710-720 (Pubitemid 38714109)
14. Ono, I.; Akasaka, Y.; Kikuchi, R.; Sakemoto, A.; Kamiya, T.; Yamashita, T.; Jimbow, K. Basic fibroblast growth factor reduces scar formation in acute incisional wounds Wound Repair Regen. 2007, 16, 617-623 (Pubitemid 47493894)
15. Lazarous, D. F.; Unger, E. F.; Epstein, S. E.; Stine, A.; Arevalo, J. L.; Chew, E. Y.; Quyyumi, A. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial J. Am. Coll. Cardiol. 2000, 36, 1239-1244
16. Hashimoto, T.; Koyama, H.; Miyata, T.; Hosaka, A.; Tabata, Y.; Takato, T.; Nagawa, H. Selective and sustained delivery of basic fibroblast growth factor (bFGF) for treatment of peripheral arterial disease: Results of a phase I trial Eur. J. Vasc. Endovasc. Surg. 2009, 38, 71-75
17. Mazué, G.; Bertolero, F.; Jacob, C.; Sarmientos, P.; Ronucci, R. Preclinical and clinical studies with recombinant human basic fibroblast growth factor Ann. N.Y. Acad. Sci. 1991, 638, 329-340
18. Casey, R.; Li, W. W. Factors controlling ocular angiogenesis Am. J. Ophthalmol. 1997, 124, 521-529 (Pubitemid 27425876)
19. Sharp, P. S. The role of growth factors in the development of diabetic retinopathy Metabolism 1995, 44, 72-75
20. Dick, I. P.; Scott, R. C. Pig ear skin as an in vitro model for human skin permeability J. Pharm. Pharmacol. 1992, 44, 640-645
21. Simon, G. A.; Maibach, H. I. The pig as an experimental model of percutaneous permeation in man: Qualitative and quantitative observations - an overview Skin Pharmacol. Appl. Skin Physiol. 2000, 13, 229-234 (Pubitemid 30666020)
22. Sekkat, N.; Kalia, Y. N.; Guy, R. H. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo J. Pharm. Sci. 2002, 91, 2376-2381 (Pubitemid 35231200)
23. Jacobi, U.; Kaiser, M.; Toll, R.; Mangelsdorf, S.; Audring, H.; Otberg, N.; Sterry, W.; Lademann, J. Porcine ear skin: an in vitro model for human skin Skin Res. Technol. 2007, 13, 19-24 (Pubitemid 46152448)
24. Franz, T. J. Percutaneous absorption. On the relevance of in vitro data J. Invest. Dermatol. 1975, 64, 190-195
25. Harrison, S. M.; Barry, B. W.; Dugard, P. H. Effect of freezing on human skin permeability J. Pharm. Pharmacol. 1984, 36, 261-262 (Pubitemid 14164802)
26. Schuetz, Y. B.; Naik, A.; Guy, R. H.; Vuaridel, E.; Kalia, Y. N. Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro Pharm. Res. 2005, 22, 1305-1312 (Pubitemid 41176034)
27. Ho, Y. C.; Mi, F. L.; Sung, H. W.; Kuo, P. L. Heparin-functionalized chitosan-alginate scaffolds for controlled release of growth factor Int. J. Pharm. 2009, 376, 69-75
28. Shen, H.; Hu, X.; Yang, F.; Bei, J.; Wang, S. Cell affinity for bFGF immobilized heparin-containing poly(lactide-co-glycolide) scaffolds Biomaterials 2011, 32, 3404-3412
29. Smith, M. L.; Carski, T. R.; Griffin, C. W. Modification of fluorescent-antibody procedures employing crystalline tetramethylrhodamine isothiocyanate J. Bacteriol. 1962, 83, 1358-1359
30. Kalia, Y. N.; Pirot, F.; Guy, R. H. Homogeneous transport in a heterogeneous membrane: water diffusion across human stratum corneum in vivo Biophys. J. 1996, 71, 2692-2700 (Pubitemid 26367731)
31. Laemmli, U. K. Cleavage of structural proteins during assembly of the head of bacteriophage T4 Nature 1970, 277, 680-685
32. Rosenberg, A. S. Effects of protein aggregates: an immunologic perspective AAPS J. 2006, 8, E501-E507
33. Schellekens, H. Factors influencing the immunogenicity of therapeutic proteins Nephrol., Dial., Transplant. 2005, 20, 3-9
34. Kasting, G. B.; Keister, J. C. Application of electrodiffusion theory for a homogeneous membrane to iontophoretic transport through skin J. Controlled Release 1989, 8, 195-210 (Pubitemid 19098999)
35. Ledger, P. W. Skin biological issues in electrically enhanced transdermal delivery Adv. Drug Delivery Rev. 1992, 9, 287-307
36. Stephen, R. L.; Petelenz, T. J.; Jacobsen, S. C. Potential novel methods for insulin administration: I. Iontophoresis Biomed. Biochem. Acta 1984, 43, 553-558 (Pubitemid 14000632)
37. Burnette, R. R.; Shen, D. M. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin J. Pharm. Sci. 1986, 75, 738-743 (Pubitemid 16016528)
38. Meyer, B. R.; Kreis, W.; Eschbach, J.; O'Mara, V.; Rosen., S.; Sibalis, D. Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteers Clin. Pharmacol. Ther. 1988, 44, 607-612 (Pubitemid 19036610)
39. Banerjee, P. S.; Ritschel, W. A. Transdermal permeation of vasopressin. I. Influence of pH, concentration, shaving and surfactant on in vitro permeation Int. J. Pharm. 1989, 49, 189-197 (Pubitemid 19053408)
40. Kumar, S.; Char, H.; Patel, S.; Piemontese, D.; Iqbal, K.; Malick, A. W.; Neugroschel, E.; Behl, C. R. Effect of iontophoresis on in vitro skin permeation of an analogue of growth hormone releasing factor in the hairless guinea pig model J. Pharm. Sci. 1992, 81, 635-639 (Pubitemid 23006787)
41. Morimoto, K.; Iwakura, Y.; Nakatani, E.; Miyazaki, M.; Tojima, H. Effects of proteolytic enzyme inhibitors as absorption enhancers on the transdermal iontophoretic delivery of calcitonin in rats J. Pharm. Pharmacol. 1992, 44, 216-218
42. Lau, D. T.; Sharkey, J. W.; Petryk, L.; Mancuso, F. A.; Yu, Z.; Tse, F. L. S. Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin®) in the rabbit Pharm. Res. 1994, 11, 1742-1746 (Pubitemid 24377085)
43. Clemessy, M.; Couarraze, G.; Bevan, B.; Puisieux, F. Mechanisms involved in iontophoretic transport of angiotensin Pharm. Res. 1995, 12, 998-1002
44. Suzuki, Y.; Nagase, Y.; Iga, K.; Kawase, M.; Oka, M.; Yanai, S.; Matsumoto, Y.; Nakagawa, S.; Fukuda, T.; Adachi, H.; Higo, N.; Ogawa, Y. Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1-34) J. Pharm. Sci. 2002, 91, 350-361 (Pubitemid 34137357)
45. Dubey, S.; Kalia, Y. N. Electrically-assisted delivery of an anionic protein across intact skin: iontophoresis of biologically active Ribonuclease T1 J. Controlled Release 2011, 152 (3) 356-362
46. Hebda, P. A.; Klingbeil, C. K.; Abraham, J. A.; Fiddes, J. C. Basic fibroblast growth factor stimulation of epidermal wound healing in pigs J. Invest. Dermatol. 1990, 95, 626-631
47. Tiede, S.; Ernst, N.; Bayat, A.; Paus, R.; Tronnier, V.; Zechel, C. Basic fibroblast growth factor: A potential new therapeutic tool for the treatment of hypertrophic and keloid scars Ann. Anat. 2009, 191, 33-44
48. Kelly, A. P. Medical and surgical therapies for keloids Dermatol. Ther. 2004, 17, 212-218 (Pubitemid 38656914)
49. Gupta, S. K.; Southam, M.; Sathyan, G.; Klausener, M. Effect of current density on pharmacokinetics following continuous or intermittent input from a fentanyl electrotransport system J. Pharm. Sci. 1998, 87, 976-981 (Pubitemid 28381255)
50. Viscusi, E. R.; Reynolds, L.; Chung, F.; Atkinson, L. E.; Khanna, S. Patient controlled transdermal fentanyl hydrochloride vs. intravenous morphine pump for postoperative pain JAMA, J. Am. Med. Assoc. 2004, 291, 1333-1341 (Pubitemid 38541648)
51. Kanebako, M.; Inagi, T.; Takayama, K. Evaluation of skin barrier function using direct current II: effects of duty cycle, waveform, frequency and mode Biol. Pharm. Bull. 2002, 25, 1623-1628 (Pubitemid 39663682)